Free Trial
→ Shots officially fired… (From Brownstone Research) (Ad)tc pixel

BioStem Technologies (OTCMKTS:BSEM) Stock Price Down 0.6% - Time to Sell?

Written by MarketBeat
October 9, 2025
BioStem Technologies logo with Medical background

Key Points

  • BioStem Technologies' stock price fell by 0.6%, trading at $4.80 after hitting a low of $4.77.
  • The company's share volume dropped by 55% compared to its average daily volume, indicating decreased trading activity.
  • BioStem Technologies focuses on the development of biologic stem cell-based products for various medical conditions, including joint pain and autoimmune diseases.
  • Five stocks to consider instead of BioStem Technologies.

BioStem Technologies, Inc. (OTCMKTS:BSEM - Get Free Report)'s share price dropped 0.6% on Wednesday . The company traded as low as $4.77 and last traded at $4.80. Approximately 32,700 shares changed hands during trading, a decline of 55% from the average daily volume of 72,406 shares. The stock had previously closed at $4.83.

BioStem Technologies Stock Down 0.6%

The business has a 50-day moving average price of $6.82 and a 200-day moving average price of $10.18. The firm has a market capitalization of $80.49 million, a price-to-earnings ratio of 4.21 and a beta of -0.44.

BioStem Technologies Company Profile

(Get Free Report)

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in BioStem Technologies Right Now?

Before you consider BioStem Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BioStem Technologies wasn't on the list.

While BioStem Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.